Akeso, Inc. is a clinical-stage bio-pharmaceutical company dedicated to addressing unmet medical needs in oncology, immunology and other therapeutic areas. The company has Akeso Comprehensive Exploration platform including target validation, antibody drug discovery and development, CMC, and GMP-compliant manufacturing. The company was established in 2019, headquartered in Zhongshan City, China.
Headquarters
6 Shennong Road, Torch Development Zone, Zhongshan
Zhongshan; Guangdong;
Postal Code: 528437
Contact Details: Purchase the Akeso, Inc. (Zhongshan) (康方生物科技开曼有限公司 (中山)) report to view the information.
Website: http://www.akesobio.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service